Osaic Holdings’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Osaic Holdings’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-107	Closed	-$1.22K	–	7548
2023 Q4	$1.22K	Hold	107	–	–	﹤0.01%	6690
2023 Q3	$430	Hold	107	–	–	﹤0.01%	7022
2023 Q2	$759	Sell	107 -103	-49%	-$713	﹤0.01%	6950
2023 Q1	$1.56K	Buy	210 +57	+37%	+$479	﹤0.01%	6807
2022 Q4	$0	Buy	153 +85	+125%	+$716	﹤0.01%	7576
2022 Q3	$1K	Hold	68	–	–	﹤0.01%	7160
2022 Q2	$1K	Sell	68 -22	-24%	-$570	﹤0.01%	7223
2022 Q1	$3K	Buy	90 +26	+41%	+$1.35K	﹤0.01%	6810
2021 Q4	$5K	Buy	+64	New	+$4.37K	﹤0.01%	6683
2020 Q4	–	Sell	-75	Closed	-$13K	–	6666
2020 Q3	$13K	Hold	75	–	–	﹤0.01%	5155
2020 Q2	$12K	Buy	+75	New	+$11.7K	﹤0.01%	5111

Osaic Holdings's HARP Position: Q1 2024 in Review

Osaic Holdings sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 107 shares — an estimated $1.22K sold.

Osaic Holdings first reported a position in HARP in Q2 2020 and held it in 11 quarters. The position peaked at $13K in Q3 2020. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Osaic Holdings reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Osaic Holdings sold 107 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.22K.
Osaic Holdings first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
Osaic Holdings's Harpoon Therapeutics, Inc. Common Stock position peaked at $13K in Q3 2020.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Osaic Holdings's 13F filing for Q1 2024, filed 10 May 2024.